Announced
Completed
Financials
Sources
Tags
Single Bidder
Cross Border
Private Equity
Completed
Minority
Private
Friendly
Venture Capital
Hong Kong
Pharmaceuticals
pharmaceutical research
Acquisition
Synopsis
Legend Capital, an investment firm based in Beijing, led a $224m Series C funding round in GenScript ProBio, a pharmaceutical research and manufacturing service provider, with participation from HighLight Capital and Xiamen C&D. The capital raising will help build up manufacturing capacity, further research and development capabilities and opportunistically acquire assets to develop its Contract Development and Manufacturing Organization business GenScript Biotech said.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.